Table 5 Profile of patients with hematological side effects
Characteristics | Leukocytosis | Neutropenia | Agranulocytosis |
|---|---|---|---|
Age | |||
 20–29 | 2 | 3 | 1 |
 30–39 | 4 | 0 | 0 |
 40–49 | 1 | 0 | 1 |
 More than 49 | 0 | 1 | 0 |
Gender | |||
 Male | 5 | 3 | 2 |
 Female | 2 | 1 | 0 |
Dose of clozapine (mgs) | |||
 Median (range) | 300 (200–400) | 450 (150–800) | 600 (400–800) |
Antipsychotics used prior to clozapine | |||
 Haloperidol | 4 | 3 | 1 |
 Chlorpromazine | 0 | 0 | 1 |
 Olanzapine | 6 | 2 | 1 |
 Resperidone | 2 | 3 | 1 |
 Quetiapine | 0 | 0 | 0 |
 Amisulpride | 2 | 0 | 0 |
 Aripiprazole | 0 | 0 | 1 |
 Paliperidone | 0 | 0 | 0 |